217 related articles for article (PubMed ID: 9378778)
1. Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor.
Mandriota SJ; Pepper MS
J Cell Sci; 1997 Sep; 110 ( Pt 18)():2293-302. PubMed ID: 9378778
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity.
Pepper MS; Mandriota SJ; Jeltsch M; Kumar V; Alitalo K
J Cell Physiol; 1998 Dec; 177(3):439-52. PubMed ID: 9808152
[TBL] [Abstract][Full Text] [Related]
3. Response of bovine endothelial cells to FGF-2 and VEGF is dependent on their site of origin: Relevance to the regulation of angiogenesis.
Cavallaro U; Tenan M; Castelli V; Perilli A; Maggiano N; Van Meir EG; Montesano R; Soria MR; Pepper MS
J Cell Biochem; 2001; 82(4):619-33. PubMed ID: 11500940
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
[TBL] [Abstract][Full Text] [Related]
5. Leukemia inhibitory factor (LIF) inhibits angiogenesis in vitro.
Pepper MS; Ferrara N; Orci L; Montesano R
J Cell Sci; 1995 Jan; 108 ( Pt 1)():73-83. PubMed ID: 7537748
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of hyaluronan oligosaccharides and vascular endothelial growth factor on angiogenesis in vitro.
Montesano R; Kumar S; Orci L; Pepper MS
Lab Invest; 1996 Aug; 75(2):249-62. PubMed ID: 8765325
[TBL] [Abstract][Full Text] [Related]
7. Synergistic induction of t-PA by vascular endothelial growth factor and basic fibroblast growth factor and localization of t-PA to Weibel-Palade bodies in bovine microvascular endothelial cells.
Pepper MS; Rosnoblet C; Di Sanza C; Kruithof EK
Thromb Haemost; 2001 Aug; 86(2):702-9. PubMed ID: 11522025
[TBL] [Abstract][Full Text] [Related]
8. Regulation of vascular endothelial growth factor receptor-2 (Flk-1) expression in vascular endothelial cells.
Pepper MS; Mandriota SJ
Exp Cell Res; 1998 Jun; 241(2):414-25. PubMed ID: 9637783
[TBL] [Abstract][Full Text] [Related]
9. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
[TBL] [Abstract][Full Text] [Related]
10. Eicosapentaenoic acid attenuates vascular endothelial growth factor-induced proliferation via inhibiting Flk-1 receptor expression in bovine carotid artery endothelial cells.
Yang SP; Morita I; Murota SI
J Cell Physiol; 1998 Aug; 176(2):342-9. PubMed ID: 9648921
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells.
Wojta J; Kaun C; Breuss JM; Koshelnick Y; Beckmann R; Hattey E; Mildner M; Weninger W; Nakamura T; Tschachler E; Binder BR
Lab Invest; 1999 Apr; 79(4):427-38. PubMed ID: 10211995
[TBL] [Abstract][Full Text] [Related]
12. Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway.
Hata Y; Rook SL; Aiello LP
Diabetes; 1999 May; 48(5):1145-55. PubMed ID: 10331422
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells. Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1.
Liu J; Razani B; Tang S; Terman BI; Ware JA; Lisanti MP
J Biol Chem; 1999 May; 274(22):15781-5. PubMed ID: 10336480
[TBL] [Abstract][Full Text] [Related]
14. Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases.
Kim MH
J Cell Biochem; 2003 Jun; 89(3):529-38. PubMed ID: 12761886
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor (VEGF) receptor-2 signaling mediates VEGF-C(deltaNdeltaC)- and VEGF-A-induced angiogenesis in vitro.
Tille JC; Wang X; Lipson KE; McMahon G; Ferrara N; Zhu Z; Hicklin DJ; Sleeman JP; Eriksson U; Alitalo K; Pepper MS
Exp Cell Res; 2003 May; 285(2):286-98. PubMed ID: 12706123
[TBL] [Abstract][Full Text] [Related]
16. Regulation of angiogenesis by controlling VEGF receptor.
Murota SI; Onodera M; Morita I
Ann N Y Acad Sci; 2000 May; 902():208-12; discussion 212-3. PubMed ID: 10865840
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.
Bussolati B; Dunk C; Grohman M; Kontos CD; Mason J; Ahmed A
Am J Pathol; 2001 Sep; 159(3):993-1008. PubMed ID: 11549592
[TBL] [Abstract][Full Text] [Related]
18. Urokinase receptor expression on human microvascular endothelial cells is increased by hypoxia: implications for capillary-like tube formation in a fibrin matrix.
Kroon ME; Koolwijk P; van der Vecht B; van Hinsbergh VW
Blood; 2000 Oct; 96(8):2775-83. PubMed ID: 11023511
[TBL] [Abstract][Full Text] [Related]
19. Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity.
Koolwijk P; van Erck MG; de Vree WJ; Vermeer MA; Weich HA; Hanemaaijer R; van Hinsbergh VW
J Cell Biol; 1996 Mar; 132(6):1177-88. PubMed ID: 8601593
[TBL] [Abstract][Full Text] [Related]
20. Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells.
Salcedo R; Zhang X; Young HA; Michael N; Wasserman K; Ma WH; Martins-Green M; Murphy WJ; Oppenheim JJ
Blood; 2003 Sep; 102(6):1966-77. PubMed ID: 12791666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
